Literature DB >> 7726487

Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics.

P A Bradford1, C C Sanders.   

Abstract

A test panel of 35 different beta-lactamases expressed in a common Escherichia coli host was created to compare the effect that each beta-lactamase had on susceptibility to various beta-lactam antibiotics. A comparison of the MICs obtained with this panel generally reflected differences in the substrate profiles of the various beta-lactamases examined. In addition, several strains of the panel were subjected to selection with porin-specific bacteriophages to obtain mutants lacking either the OmpC or OmpF porin protein. A mutation in either OmpC or OmpF did change the susceptibilities of certain strains expressing beta-lactamase to certain beta-lactam antibiotics. However, the loss of a single porin did not predictably alter susceptibility to any given beta-lactam drug. This panel of strains producing various beta-lactamases was found to be a useful tool for comparing the effects of different beta-lactamases and outer membrane permeability upon susceptibility to beta-lactam drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726487      PMCID: PMC162532          DOI: 10.1128/AAC.39.2.308

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  59 in total

1.  Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa.

Authors:  A M Philippon; G C Paul; A P Thabaut; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

2.  Conjugative transfer of staphylococcal antibiotic resistance markers in the absence of detectable plasmid DNA.

Authors:  N el Solh; J Allignet; R Bismuth; B Buret; J M Fouace
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.

Authors:  P C Fuchs; R N Jones; A L Barry; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae.

Authors:  N Datta; P Kontomichalou
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

5.  Five novel plasmid-determined beta-lactamases.

Authors:  A A Medeiros; M Cohenford; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

7.  Characterization of beta-lactamases in situ on polyacrylamide gels.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

8.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

9.  Plasmid penicillin resistance in Vibrio cholerae: identification of new beta-lactamase SAR-1.

Authors:  A J Reid; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

10.  Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Diagn Microbiol Infect Dis       Date:  1986-04       Impact factor: 2.803

View more
  8 in total

1.  Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  C C Sanders; M Peyret; E S Moland; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae.

Authors:  A F Ehrhardt; C C Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

4.  Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Authors:  K S Thomson; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.

Authors:  C Hal Jones; Alexey Ruzin; Margareta Tuckman; Melissa A Visalli; Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

6.  Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

Authors:  M G Cormican; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

7.  Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.

Authors:  Peter J Petersen; C Hal Jones; Aranapakam M Venkatesan; Tarek S Mansour; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

8.  Analysis and comparative genomics of R997, the first SXT/R391 integrative and conjugative element (ICE) of the Indian Sub-Continent.

Authors:  Michael P Ryan; Patricia Armshaw; John A O'Halloran; J Tony Pembroke
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.